Company / Income Tax per Share
Avalo Therapeutics, Inc. Income Tax per Share History
FY2017-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Income Tax per Share
$0.02
FY2025
5-year range
-$0.00 / $0.36
FY2021-FY2025
Trend
-88.9%
vs FY2024
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Income Tax per Share has fluctuated over the past 9 years, ranging from $-0.06 in FY2020 to $0.36 in FY2023.
Based on SEC 10-K filings.
0.02 in FY2025 with a 3-year CAGR of +74.2%.
Improved from $0.36 to $0.02 over the past 2 years.
Income Tax per Share over time
Growth rates
- 3-Year CAGR
- +74.2%
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Key checks
Key Insights
- In FY2025, income tax per share decreased 88.9% year-over-year.
- Peak income tax per share was recorded in FY2023.
- Lowest income tax per share in the period was in FY2020.
Company context
Key Data Points
- Low Piotroski F-Score: 1/9 (multiple financial health concerns)
- Altman Z-Score -3.59 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Income Tax per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $0.02 | -88.9% |
| FY2024 | $0.14 | -60.1% |
| FY2023 | $0.36 | +11860.5% |
| FY2022 | $0.00 | +214.0% |
| FY2021 | -$0.00 | +95.8% |
| FY2020 | -$0.06 | -1016.0% |
| FY2019 | $0.01 | +534.2% |
| FY2018 | -$0.00 | -100.8% |
| FY2017 | $0.21 | - |
As of FY2025 · SEC Form 10-K · Last checked Jun 21, 2026